tiprankstipranks
Trending News
More News >

Shanghai Haohai Biological Technology Announces 2025 H Shareholders’ Meeting

Story Highlights
Shanghai Haohai Biological Technology Announces 2025 H Shareholders’ Meeting

Confident Investing Starts Here:

The latest update is out from Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ).

Shanghai Haohai Biological Technology Co., Ltd. has announced a 2025 first H shareholders’ class meeting scheduled for June 10, 2025, following their 2024 annual general meeting. During this meeting, a special resolution will be considered to grant the Board a general mandate to repurchase up to 10% of the H Shares in issue. This move is aimed at optimizing the company’s capital structure and enhancing shareholder value, reflecting strategic positioning in the market.

More about Shanghai Haohai Biological Technology Co., Ltd. Class H

Shanghai Haohai Biological Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on the biotechnology industry. The company is involved in the development and production of biological products, leveraging advanced technologies to cater to various market needs.

Average Trading Volume: 585,957

Technical Sentiment Signal: Sell

Current Market Cap: HK$12.06B

For a thorough assessment of 6826 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App